Pérol L, et al. have already shown the existence of anti-IL-2 autoantibodies in non-obese diabetic mice and Type 1 Diabetes patients, and the IL-2 may serve as an autoimmune target for patients with Type 1 Diabetes [97]. Here, IL2 is linked to type 1 diabetes mellitus.